UK BMT Pharmacists’ Group Educational Meeting

The UK BMT Pharmacists’ Group (a special-interest group affiliated to BOPA) is running an educational meeting at University College Hospital (UCH Education Centre, 250 Euston Road, London NW1 2PG) on the afternoon of Friday 13th March.

Although the meeting will have a transplant-focus, we have tried to make the agenda fairly broad, and all pharmacists with an interest in haematology are very welcome to attend.

There is no registration fee and no need to pre-register but it would help from a logistical point of view if you could email: [email protected]  if you are planning to attend

BMT meeting Agenda March 2020

Thanks – Nick Duncan and the BOPA Committee

Latest News

By BOPA Research committee on 18th June 2025

Share Your Insights – The use and development of ChemoCare Electronic Prescribing System for systemic anti-cancer therapy

Dear Oncology/Haematology Pharmacist, You are invited to participate in a survey exploring the factors that influence UK-registered pharmacists’ use and the development of ChemoCare Electronic Prescribing system (EPS) for systemic…

Read article
By BOPA Education & Training Sub-Committee on 17th June 2025

New CINV e-learning module

The Education and Training subcommittee are pleased to announce that our new e-learning module for Chemotherapy-induced Nausea and Vomiting (CINV) is now live on the BOPA website. The module can…

Read article
By BOPA E&T Subcommittee on 12th June 2025

BOPA E&T Webinar: Harnessing AI in Oncology Pharmacy Practice – Focus on Administrative Efficiency

Friday 20th June 2025 at 12:00 BST   Click HERE to register   The BOPA Education and Training Subcommittee would like to invite you to the E&T Webinar: Harnessing AI…

Read article
By BOPA Research Committee on 8th June 2025

Calling all cancer service pharmacy managers to complete this survey!

BOPA and SOPPG (Scottish Oncology Pharmacy Practice Group) are collaborating to validate and hopefully publish an oncology pharmacy workforce tool.  We need the tool to be trialled to validate and…

Read article